PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCholestyramine
Cholestyramine
Cholestyramine, Locholest, Prevalite (cholestyramine) is a small molecule pharmaceutical. Cholestyramine was first approved as Questran on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Cholestyramine, Locholest, Prevalite (discontinued: Cholestyramine, Cholybar, Questran)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cholestyramine
Tradename
Company
Number
Date
Products
QUESTRANBristol Myers SquibbN-016640 DISCN1982-01-01
2 products, RLD
QUESTRAN LIGHTBristol Myers SquibbN-019669 DISCN1988-12-05
2 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
cholestyramineANDA2024-11-15
cholestyramine for oral suspensionANDA2023-01-09
cholestyramine lightANDA2024-07-24
cholestyramine powder for suspensionANDA2024-12-27
prevaliteANDA2020-06-18
questranANDA2019-11-01
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
C10: Lipid modifying agents
C10A: Lipid modifying agents, plain
C10AC: Bile acid sequestrants
C10AC01: Colestyramine
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameCholestyramine
INNcolestyramine
Description
Colestyramine (INN) or cholestyramine (USAN) (trade names Questran, Questran Light, Cholybar, Olestyr) is a bile acid sequestrant, which binds bile in the gastrointestinal tract to prevent its reabsorption. It is a strong ion exchange resin, which means it can exchange its chloride anions with anionic bile acids in the gastrointestinal tract and bind them strongly in the resin matrix. The functional group of the anion exchange resin is a quaternary ammonium group attached to an inert styrene-divinylbenzene copolymer.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID11041-12-6
RxCUI
ChEMBL IDCHEMBL1201625
ChEBI ID
PubChem CID70695640
DrugBankDB01432
UNII ID4B33BGI082 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Cholestyramine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use